Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Cel-Sci purchases complete rights to Multikine

March 11, 1997

AltaRex receives funding for clinical trials on Ovarex

March 10, 1997

IDEC and Roche submit applications for IDEC-C2B8

March 5, 1997

ONYX expands ONYX-015 clinical trials

March 4, 1997

Roche's Roferon-A receives EU approval

March 4, 1997

IGG's MMS-1 covered by patent

March 3, 1997

Immunotherapy cancer vaccine in phase II

Feb. 20, 1997

Encouraging results obtained for immunotoxin in Hodgkin's lymphoma

Feb. 17, 1997

Labeled SMART antibody shows promise for AML treatment

Feb. 17, 1997

Maxim's lead product approaches pivotal trials

Feb. 12, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...